The induction and persistence of altered sphingolipid biosynthesis in rats treated with fumonisin B1

Food Additives and Contaminants

Volumn 18, Issue 9, 2001, Pages 850-856

  Garren, L ^a   Galendo, D ^a   Wild, C P ^b   Castegnaro, M ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Kidney; Liver; Sa So ratio; Sphinganine (Sa); Sphingosine (So); Urine

Indexed keywords

BIOCHEMICAL MARKER; CARCINOGEN; ENZYME INHIBITOR; FUMONISIN B1; MYCOTOXIN; SPHINGANINE; SPHINGOLIPID; SPHINGOSINE; SPHINGOSINE ACYLTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOSYNTHESIS; BLOOD ANALYSIS; CARCINOGEN TESTING; CARCINOGENICITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ESOPHAGUS; EXPOSURE; FEEDING; FUSARIUM; KIDNEY PARENCHYMA; LIPID METABOLISM; LIPOGENESIS; LIVER CARCINOGENESIS; LUNG CARCINOGENESIS; MALE; METABOLIC DISORDER; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM; TISSUE SECTION; TOXICITY TESTING; URINALYSIS;

ANIMALS; BIOLOGICAL MARKERS; CARBOXYLIC ACIDS; CARCINOGENS, ENVIRONMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FUMONISINS; KIDNEY; LIVER; MALE; MYCOTOXINS; RATS; RATS, INBRED STRAINS; SPHINGOSINE;

ANIMALIA; FUSARIUM; RODENTIA;

EID: 0034839208     PISSN: 0265203X     EISSN: 14645122     Source Type: Journal    
DOI: 10.1080/02652030120881     Document Type: Article

References (38)

1. Abbas, H. K., Cartwright, R. D., Shier, W. T., Abouzied, M. M., Bird, C. B., Rice, L. G., Ross, P. F., Sciumbato, G. L., and Meredith, F. I., 1998, Natural occurrence of fumonisin in rice with fusarium sheath rot disease. Plant Disease, 82, 22-25.
2. Bezuidenhout, S. C., GeLderbLom, W. C. A., Gorst-ALLman, C. P., Horak, R. M., Marasas, W. F. O., SpiteLLer, G., and VLeggar, R., 1988, Structure elucidation of the fumoni-sins, mycotoxins from Fusarium moniliforme. Journal of the Chemical Society, Chemical Communications, 11, 743-745.
3. Castegnaro, M., 1999a, Risques cancerogenes. Les Mycotoxines dans l’Alimentation, (valuation et Gestion du Risque, edited by Conseil Supérieur d’Hygiene Publique de France, pp. 121-140.
4. Castegnaro, M., 1999b, Analyse des biomarqueurs d’exposition. Les Mycotoxines dans l’Alimentation (valuation et Gestion du Risque, edited by Conseil Supérieur d’Hygiène Publique de France, pp. 173-196.
5. Castegnaro, M., Garren, L., Gaucher, I., and WiLd, C.P., 1996, Development of a new method for the analysis of sphinganine and sphingosine in urine and tissues. Natural Toxins, 4, 284-290.
6. Castegnaro, M., Garren, L., Galendo, D., Gelderblom, W. C., Chelule, P., Dutton, M., and Wild, C. P., 1998, Analytical method for the determination of sphinganine and sphingosine in serum as a potential biomarker for fumonisin exposure. Journal of Chromatography, 720, 15-24.
7. Enongene, E. N., Sharma, R. P., Bhandari, N., Voss, K. A., and Riley, R. T., 2000, Disruption of sphingolipid metabolism in small intestines, liver and kidney of mice dosed subcutaneously with fumonisin B1. Food and Chemical Toxicology, 38, 793-799.
8. Gelderblom, W. C. A., Jaskiewicz, K., Marasas, W. F. O., Thiel, P. G., Horak, R. M., Vleggaar, R., and Kriek, N. P. J., 1988, Fumonisins—novel mycotoxins with cancer-promoting activity produced by Fusarium moniliforme. Applied and Environmental Microbiology, 54, 1806-1811.
9. Gelderblom, W. C. A., Semple, E., Marasas, W. F. O., and Farber, E., 1992, The cancer-initiating potential of the fumonisin B mycotoxins. Carcinogenesis, 13, 433-437.
10. 1 on the levels and fatty acid composition of selected lipids in rat liver in vivo. Food and Chemical Toxicology, 37, 647-656.
11. Gold, L. S., Sawyer, C. B., Magaw, R., Backman, G. M., De Veciana, M., Levison, R., Hoopewr, N. K., Havender, W.R., Bernstein, L., Peto, R., Pike, M. C., and Ames, B., 1984, A carcinogenic potency database of the standardized results of animal bioassays. Environmental Health Perspectives, 5, 9-319.
12. 1, a toxic metabolite of Fusarium moniliforme. Journal of Veterinary Diagnostic Investigation, 2, 217-221.
13. IARC, 1993, IARC Monographs on the Evaluation of Carcinogenic Risks of Chemicals to Humans. Volume 56: Some Naturally Occurring Substances: Some Food Items and Constituents, Heterocyclic Aromatic Amines and Mycotoxins (Lyon: IARC).
14. 2 in Fusarium pro-liferatum infected asparagus plants. Journal of Agricultural and Food Chemistry, 46, 5201-5204.
15. Marasas, W. F. O., 1996, Fumonisins. History, worldwide occurrence and impact. Fumonisins in Food, edited by L. S. Jackson, J. W. DeVries and L. B. Bullernan (New York: Plenum Press), pp. 117.
16. Marasas, W. F. O., Kellerman, T. S., Gelderblom, W. C. A., Coetzer, J. A. W., Thiel, P. G., and van der Lugt, J. J., 1988, Leukoencephalomalacia in a horse induced by fumonisin B1 isolated from Fusarium moniliforme. Onderstepoort Journal of Veterinary Research, 55, 197-203.
17. 1 mice (feed studies). Draft technical report TR-496 (Abstract available on the web at the following address: http://ntp-server.niehs.nih.gov/htdocs/LT-studies/TR496.html).
18. 1 (CAS No. 116355-83-0) in F344/N rats and B6C3F1 mice (feed studies). NCTR Report TR496. 21 May draft.
19. Nelson, P. E., Plattner, R. D., Shackelford, D. D., And Desjardins, A. E., 1991, Production of fumonisins by Fusarium moniliforme strains from various substrates and geographic area. Applied and Environmental Microbiology, 57, 2410-2412.
20. Nelson, P. E., Plattner, R. D., Shackeuord, D. D., And Desjardins, A. E., 1992, Production of fumonisins by Fusarium species other than F. moniliforme in section Liseola and by some related species. Applied and Environmental Microbiology, 58, 984-989.
21. Pforn-Leszkowicz, A., 1999, Effets biologiques et pathologies. Les Mycotoxines dans l’Alimentation, (valuation et Gestion du Risque, edited by Conseil Supérieur d’Hygiene Publique de France, pp. 69-117.
22. Pforn-Leszkowicz, A., and Castegnaro, M., 1999, Fumonisines. Les Mycotoxines dans l’alimentation, (valuation et Gestion du Risque, edited by Conseil Supérieur d’Hygiene Publique de France, pp. 295-330.
23. 1 stimulates the arachidonic acid cascade and cAMP production. Carcinogenesis, 20, 1683-1688.
24. Pittet, A., 1998, Natural occurrence of mycotoxins in foods and feeds. A review. Revue de Médecine Vétérinaire, 149, 479-492.
25. Qiu, M., and Liu, X., 2001, Determination of sphinganine, sphingo-sine and Sa/So ratio in urine of humans exposed to dietary fumonisin B1. Food Additives and Contaminants, 18, 263-269.
26. 1 induces disruption of sphingolipid metabolism in Sprague Dawley rats: a new mechanism of nephrotoxicity. Journal of Nutrition, 124, 594-603.
27. Riley, R. T., Wang, E., and Merrill, A. H., Jr, 1994b, Liquid chromatographic determination of sphinganine and sphingo-sine: use of free sphinganine-to-sphingosine ratio as a biomarker for consumption of fumonisins. Journal of AOAC International, 77, 533-540.
28. Riley, R. T., Wang, E., Schroeder, J. J., Smith, E. R., Planner, R. D., Abbas, H., Yoo, H. S., And Merrill, A. H. Jr, 1996, Evidence for disruption of sphingolipid metabolism as a contributing factor in the toxicity and carcinogenicity of fumoni-sins. Natural Toxins, 4, 3-15.
29. Shephard, G. S., Thiel, P. G., Stockenstrôm, S., and Sydenham, E. W., 1996, Worldwide survey of fumonisin contamination of corn and corn-based products. Journal of AOAC International, 79, 671-687.
30. Solfrizzo, M., Avantaggiato, G., and Visconti, A., 1997, Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. Journal of Chromatograph y B, 692, 87-93.
31. 3 in food and feeds. Journal of AOAC International, 75, 313-318.
32. Tseng, T.C., Tu, J.C., and Soo, L.C., 1995, Natural occurrence of mycotoxins in Fusarium infected beans. Microbios, 84, 21-28.
33. Turner, P. C., Nikiema, P., and Wild, C. P., 1999, Fumonisin contamination of food: progress in development of biomarkers to better assess human health risks. Mutation Research, 443, 8193.
34. van der Westhuizen, L., Brown, N. L., Marasas, W. F. O., Swanevelder, S., and Shephard, G. S., 1999, Sphinganine/sphingosine ratio in plasma and urine as a possible biomarker for fumonisin exposure in humans in rural areas of Africa. Food and Chemical Toxicology, 37, 1153-1158.
35. 3 cause hepato- and nephrotoxicity in rats. Mycopathologia, 141, 45-48.
36. Wang, E., Norred, W. P., Bacon, C. W., Riley, R. T., and Merrill, A. H. Jr, 1991, Inhibition of sphingolipids biosynthesis by fumonisins. Implication for diseases associated with Fusarium moniliforme. Journal of Biological Chemistry, 266, 14486-14490.
37. 1 consumption by rats causes reversible, dose-dependent increases in urinary sphinganine and sphingo-sine. Journal of Nutrition, 12, 214-220.
38. Wild, C. P., Daudt, W. A., and Castegnaro, M., 1998, The molecular epidemiology of mycotoxin related disease. Mycotoxins and phycotoxins—Developments in Chemistry, Toxicology and Food Safety, edited by M. Miraglia, H.P. van Egmond, C. Brera and J. Gilbert (Fort Collins, CO: Alaken, Inc.), pp. 213-231.